The effect of deprenyl and levodopa on the progression of Parkinson's disease
C. Warren Olanow(Icahn School of Medicine at Mount Sinai), Joy Esterlitz, Robert A. Hauser(University of South Florida), L. Gauguster(University of South Florida), David E. Lilienfeld, Teri Malapira(University of South Florida), William C. Koller(Stanford University), Jean Hubble(The Ohio State University), K. Bushenbark(University of Kansas)
Cited by 335
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Variable expression of Parkinson's disease
|Neurology|1990|1.3k